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Our understanding of effective perioperative supportive interventions for patients undergoing 14 
cystectomy procedures and how these may affect short and long-term health outcomes is limited.  15 
Methods 16 
Randomised controlled trials involving any non-surgical, perioperative interventions designed to 17 
support or improve the patient experience for patients undergoing cystectomy procedures were 18 
reviewed. Comparison groups included those exposed to usual clinical care or standard procedure. 19 
Studies were excluded if they involved surgical procedure only, involved bowel preparation only or 20 
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involved an alternative therapy such as aromatherapy. Any short and long-term outcomes reflecting 21 
the patient experience or related urological health outcomes were considered. 22 
Results 23 
19 articles (representing 15 individual studies) were included for review. Heterogeneity in 24 
interventions and outcomes across studies meant meta-analyses were not possible. Participants 25 
were all patients with bladder cancer and interventions were delivered over different stages of the 26 
perioperative period. The overall quality of evidence and reporting was low and outcomes were 27 
predominantly measured in the short-term. However, the findings show potential for exercise 28 
therapy, pharmaceuticals, ERAS protocols, psychological/educational programmes, chewing gum 29 
and nutrition to benefit a broad range of physiological and psychological health outcomes. 30 
Conclusions 31 
Supportive interventions to date have taken many different forms with a range of potentially 32 
meaningful physiological and psychological health outcomes for cystectomy patients. Questions 33 
remain as to what magnitude of short-term health improvements would lead to clinically relevant 34 
changes in the overall patient experience of surgery and long-term recovery.  35 
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Background 38 
Perioperative complications from cystectomy and urinary diversion can be short- and long-term, 39 
physiological and psychological [1]. Postoperative morbidity and complication rates can lead to long 40 
hospital stays [2] and high readmission rates [3]. Surviving patients can experience emotional, 41 
physical and social challenges and changes in quality of life (QOL) [1]. The range of perioperative 42 
complications associated with cystectomy procedures requires a multidisciplinary approach to 43 
preoperative supportive care and postoperative rehabilitation [4].  44 
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Perioperative interventions should support patients' psychological health as much as physical health 45 
[5]. The optimal perioperative supportive interventions for cystectomy patients and associated 46 
health outcomes are currently uncertain. Evidence-based interventions have traditionally been non-47 
standardised but have evolved into clinical pathways of care known as enhanced recovery after 48 
surgery (ERAS) protocols. ERAS protocols involve a series of perioperative care modifications and 49 
supportive interventions with the aim to achieve early recovery by maintaining preoperative organ 50 
function and reducing physiological stress response following surgery [6]. ERAS protocols after 51 
cystectomy have had a low adoption [7], yet have been found to shorten hospital stay [3] without an 52 
increase postoperative morbidity [8]. Our understanding of the active ingredients of such protocols 53 
and how these may affect the overall patient experience in the long-term is limited and previous 54 
comprehensive reviews have involved non-randomised observational studies only [9] . Further 55 
exploration of the available evidence using rigorous systematic review methodology is required to 56 
develop our understanding of how to promote clinically relevant health outcomes for cystectomy 57 
patients. 58 
The aim of this review is to summarise the available evidence base for any supportive interventions 59 
designed to improve short and/or long-term physiological and psychological health outcomes among 60 
patients undergoing cystectomy. Reviewing the literature of the wide range of perioperative 61 
supportive interventions and their related health outcomes will advance our understanding of what 62 
works for patients undergoing cystectomy.   63 
Methods 64 
A systematic review of the literature was performed in January 2018. Records were identified from 65 
MEDLINE, AMED, PsycInfo and EMBASE databases and the Cochrane collaboration. The search was 66 
limited to studies involving adult humans and published in the English language and not limited by 67 
date of publication. Literature search terms are available as supplementary material (see Additional 68 
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file 1). Further searches were made for unpublished and grey literature. The 69 
http://www.clinicaltrials.gov website was searched for ongoing trials. The citation lists of included 70 
studies and previous systematic reviews were also checked to identify relevant studies. 71 
Randomised controlled trials (RCTs) involving any non-surgical, perioperative interventions designed 72 
to support or improve the patient experience, including lifestyle, physical, medical and psychological 73 
treatments were considered for review. The intention was not to assess the effects of different 74 
forms of surgical diversion. Studies were eligible if they involved adults ≥ 18 years who were due to 75 
undergo or had undergone a cystectomy procedure and any method of urinary diversion. Supportive 76 
interventions could be implemented during diagnosis and treatment planning, the perioperative 77 
period, and during the length of hospital stay, follow-up and postoperative period. Interventions 78 
could be hospital-based or home-based. Comparison groups included those exposed to usual clinical 79 
care or standard procedure. Studies were excluded if they did not involve an intervention, or the 80 
intervention involved a surgical procedure only, bowel preparation only or an alternative therapy 81 
such as aromatherapy. Any outcomes reflecting the patient experience or related urological health 82 
outcomes were considered and could be physiological, psychological, behavioural and social. 83 
Data collection and analysis 84 
Selection of studies  85 
Following de-duplication, titles and abstracts of identified records were screened by one reviewer 86 
(HQ) and 10 per cent were selected at random and checked independently by a second reviewer 87 
(LB). The full texts of potentially eligible records were retrieved and screened independently by the 88 
two reviewers (HQ, LB). Multiple records of the same study were linked together in the process. The 89 
study selection process is described in the PRISMA flow diagram (Figure 1).  90 
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Figure 1. Flowchart describing the process of identifying relevant literature 91 
Data extraction and management  92 
The full text of each article was read by two reviewers independently (HQ, LB) and after piloting of 93 
extraction tables, relevant data were extracted. Any discrepancies in data extraction between the 94 
two reviewers were resolved by discussion. The authors of included studies were contacted via email 95 
for clarification of unclear study methods or data wherever insufficient details were reported.  96 
Assessment of risk of bias in included studies 97 
The risk of bias of each included study was assessed by two reviewers (HQ, LB) working 98 
independently using the recommended tool in the Cochrane Handbook for Systematic Reviews of 99 
Intervention [10]. Any disagreements were resolved by discussion.  100 
Dealing with missing data 101 
Missing data and dropout rates for each of the included studies were assessed. When possible, all 102 
data extracted were relevant to an intention-to-treat analysis, in which participants were analysed in 103 
the groups to which they were assigned.  104 
Assessment of heterogeneity and sensitivity analyses 105 
Statistical methods for assessing heterogeneity and sensitivity analyses were planned, depending on 106 
the availability of data. 107 
Data synthesis and statistical analysis 108 
Meta-analyses were planned for wherever there was more than one RCT reporting the same 109 
outcome. Where meta-analyses were not feasible, a narrative synthesis approach was used [11]. 110 
Results 111 
The search identified 63 articles meeting the inclusion criteria for full text screening (Figure 1). In all, 112 
44 articles were excluded and the reasons recorded. The remaining 19 articles (representing 15 113 
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individual studies) were included in the review. Studies were published between 1989 [12] and 2017 114 
[13-15] and were conducted in ten different countries; one was UK-based [14] (see Table 1). 115 
[insert Table 1 here] 116 
Participants 117 
Table 1 provides a summary of participant characteristics. All studies involved patients with bladder 118 
cancer undergoing radical cystectomy. Sample sizes ranged from 8 [15] to 280 [16], with a total of 119 
1,145 participants across all studies. The average age of participants ranged from 45.3 years (mean) 120 
[12] to 74.5 years (median) [15]. Most studies included both sexes, except two studies that included 121 
males only [15, 17]. Other patient characteristics, though not reported consistently included BMI, 122 
ethnicity, comorbidities, smoking history, and socio-economic data. 123 
Interventions 124 
See Table 2 for a summary of interventions included in this review.  125 
[insert Table 2 here] 126 
Type 127 
Intervention types included; exercise therapy [14, 18-21], pharmaceutical [16, 22, 23], ERAS protocol 128 
[17, 24, 25], psychological/educational [1, 12, 13, 15], chewing gum [26], and nutritional [27-29]. 129 
Interventions were delivered by exercise science staff [14], physiotherapists [18-21], Urological 130 
Enteral Stoma Therapy Nurses [13],  trained nurse practitioners [15], hospital ward staff [27], and 131 
staff nurses [23], healthcare professionals [17] and study investigator [26]. Seven did not report who 132 
delivered the intervention [1, 12, 16, 22, 24, 25, 28]. Treatments to control group patients were 133 
determined by the standard procedure at the local hospital which may have involved some ERAS 134 
items [18-20, 25] and were not consistent across studies. 135 
Recruitment and intervention setting 136 
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The majority of studies recruited participants via a single hospital urology department, two studies 137 
recruited across multiple centres [16, 28] and three did not report recruitment setting [1, 22, 24].  138 
Intervention settings were hospital based [12, 15-17, 22-29], hospital and home based [13, 18-21], 139 
home-based [1] or supervised exercise setting [14].  140 
Time, duration and frequency 141 
Studies varied in time of intervention delivery; preoperative, postoperative or perioperative (see 142 
Table 2). Duration of intervention varied from 30-60 minutes for a single educational intervention 143 
[12, 15] to 12 weeks for the physical exercise intervention [21]. Six studies did not have standardised 144 
intervention duration; Banerjee et al.'s (2017) exercise intervention took place preoperatively until 145 
surgery, Choi et al.'s (2010) chewing gum intervention continued until first flatus, Deibert et al.'s 146 
(2016) dietary intervention was postoperative until discharge [28], and those studies implementing 147 
ERAS protocols took place over the perioperative period until discharge [17, 24, 25]. Frequency of 148 
intervention administration differed depending on the intervention type (see Table 2). 149 
Measurements 150 
Methods of measuring outcomes varied across studies, making direct comparisons between studies 151 
difficult. Hospital records were used to measure length of stay (LOS) and readmission rate. Hospital 152 
measurements were used to assess functions such as bowel function and flatus, food tolerance and 153 
mobilisation. Complications were assessed using the standardised Clavien-Dindo classification 154 
system [14, 17, 20, 25-28] or via hospital reports. Symptoms (e.g., pain, fatigue, vomiting) tended to 155 
be self-reported using patient questionnaires. Three studies [18, 24, 25] used the validated European 156 
Organisation for Research and Treatment of Cancer (EORTC) [30] to assess quality of life (QOL), and 157 
in-patient satisfaction. Three studies used a visual analogue scale (VAS) to measure pain intensity 158 
[22, 23, 28], one study used Sickness Impact Profile (SIP) to measure sickness-related dysfunction 159 
and postoperative adjustment [1], two studies used the Short Form health survey (SF-36 and SF-12) 160 
to evaluate health-related QOL [21, 29], one used the Functional Assessment of Cancer Therapy- 161 
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Bladder Cancer (FACT-BL) questionnaire to measure QOL [25] and one used the State-Trait Anxiety 162 
Inventory (STAI) to measure state anxiety [12]. Self-care was measured using the Urostomy 163 
Education Scale (UES) [13]. Self-efficacy was measured using the six-item Self-Efficacy to Manage 164 
Chronic Disease (SES6G) scale [15].  165 
Outcome measurement (length of follow-up) tended to be short term (up to 30 days 166 
postoperatively) in the majority of articles reviewed (n=11), and ranged between 24 hours 167 
postoperatively [23] to a median of 50 months after surgery (IQR 21-62 months) [29] (See Table 2). 168 
Effect of interventions  169 
The outcomes used to measure the effect of interventions are summarised in Table 3. Differences in 170 
definitions and measurements of outcomes across studies meant that meta-analyses were not 171 
possible.  172 
[insert Table 3 here] 173 
Length of stay and readmission 174 
Length of stay (LOS) was reported in eleven articles [1, 14, 16, 17, 20, 21, 24-28]. The most common 175 
definition of LOS was total hospital stay duration in days. Two studies defined it as postoperative 176 
days (from surgery until discharge) [1, 16]. Median LOS ranged from 7 [14] to 21 days [1]. Frees et al. 177 
(2017) and Lee et al. (2014) found a significant difference in LOS between intervention and control 178 
groups. Frees et al. found LOS was significantly shorter in the patients receiving ERAS protocol 179 
compared to standard procedure (mean 6.1 days vs. 7.39 days; p=0.020). Lee et al. found mean LOS 180 
was significantly shorter in patients given alvimopan compared to placebo controls (alvimopan, 7.44 181 
days; control 10.07 days; p<0.01).  182 
Frequency of readmission to hospital after discharge was measured as an outcome in five studies 183 
[16, 20, 21, 25, 28]. No study reported significant results for readmission rates after supportive 184 
intervention compared to controls.  185 
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Physiological adjustment after surgery 186 
Bowel function and flatus 187 
Nine studies measured bowel function [18, 20, 27, 28], also defined as time to first defecation or 188 
bowel movement [17, 25, 26], constipation [24] and lower gastrointestinal function [16]. Statistically 189 
significant reductions in average time until first bowel movement were found in four studies after 190 
the intervention; ERAS protocol [25], chewing gum [26], physical exercise [18] and alvimopan [16]. 191 
Time to first flatus was measured in five studies [17, 18, 25-27] and three found statistically 192 
significant reductions in time after ERAS protocol [25], chewing gum [26] and physical exercise [18]. 193 
Frees et al. (2017) found significant reduction in time to first flatulence in the ERAS group compared 194 
to the standard procedure controls (2.5 days compared to 3.62 days) (p=0.011). 195 
Food tolerance  196 
Six studies measured food tolerance, defined at nutritional intake [20], appetite loss [24], 197 
gastrointestinal recovery/tolerance of solid food [16], early feeding [17] and resumption of full diet 198 
[27]. Deibert et al. (2017) found time to full diet tolerance was the same in both early diet and 199 
control arms, respectively (5.84 days vs 6.71days, p=0.27). Lee et al. (2014) found mean time to 200 
gastrointestinal recovery was 1.3 days shorter for the alvimopan group (5.5 days) compared with the 201 
placebo control group (6.8 days; 95% CI, 1.4 to 2.3; p<0.0001). Karl et al. (2014) found that the 202 
amount of food consumed in relation to the amount of food offered on postoperative day 3 was 203 
significantly higher in the ERAS group compared to standard procedure controls (p=0.02).  204 
Nausea and vomiting  205 
Four studies measured vomiting [22], nausea [25] or both [18, 24] and none reported any significant 206 
differences between intervention and control groups after the intervention. 207 
Pain  208 
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Six studies measured pain [18, 21-25]. Three studies reported statistically significant pain outcomes. 209 
Ghoneim & Hegazy (2013) found VAS score to be significantly lower postoperatively until 32 hours in 210 
the intervention group receiving preoperative pregabalin compared to the control group (p<0.05), 211 
but found no significant difference 32-48 hours postoperatively. Mohamed et al. (2016) found a 212 
significant reduction in VAS score in intervention groups who received preoperative pregabalin in 213 
comparison with the control group immediately after surgery, and 2 hours postoperatively (p<0.05). 214 
Frees et al. (2017) found ERAS patients reported a reduction in VAS score every day after surgery 215 
until day 7 compared to patients undergoing standard procedure. This difference reached statistical 216 
significance on the day of surgery (p=0.017) and from postoperative days 2 (p=0.014) to 4 (p=0.039), 217 
where pain intensity was nearly doubled for patients who received standard procedure.  218 
Fatigue 219 
Two studies measured fatigue using the EORTC symptom scale [18, 24]. Jensen et al. (2014) found 220 
the control group (no physical exercise intervention) demonstrated a clinically relevant reduction in 221 
fatigue symptoms at 4 months follow-up that was not statistically significant. Karl et al. (2014) 222 
reported significant differences in fatigue scores between the ERAS and control group at day 7 223 
(p=0.014) and discharge (p=0.003), but did not report the group data. 224 
Mobilisation, strength/power and balance 225 
Three studies measured mobilisation [20, 21, 24], defined as the distance walked during the first 226 
seven postoperative days [20], mobilisation and walking distance [24] and distance walked in the six 227 
minute walk test [21]. Jensen et al. (2015) reported significantly longer average walking distance in 228 
the intervention group after the physical exercise intervention (4806 metres walked; 95% CI, 4075 to 229 
5536m), compared to the control group (2906 metres walked; 95% CI, 2408 to 3404 m; p<0.001). 230 
Karl et al. (2014) reported that patients in the ERAS group covered significantly greater walking 231 
distances by postoperative day 3 compared to controls (p=0.039). Porserud et al. (2014) found that 232 
after the 12 week exercise training period, both the intervention and the control group patients had 233 
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increased the distance walked (p=0.043 and p=0.012, respectively), but the increase was higher 234 
among the intervention group (p=0.013) who had exercised postoperatively. One year later, the 235 
exercise group continued to have increased walking distance compared to controls (p=0.010). 236 
The three studies using exercise therapy measured strength or power. Jensen et al. (2016) measured 237 
strength as muscle leg power (W/kg) using a leg extensor power test and found that the 238 
prehabilitation physical exercise programme led to a significant improvement in muscle power in the 239 
intervention group of 0.35 W/kg (95% CI, 0.12 to 0.54) at time for surgery compared to baseline 240 
(p<0.002) with a significant difference between intervention and control group [19]. Banerjee et al. 241 
(2017) implemented a short-term preoperative vigorous intensity aerobic interval exercise 242 
programme on a cycle ergometer and showed that after 3-6 weeks of training, statistically significant 243 
differences in peak power output (W) were found between the exercise group (148±41; 95% CI, 132 244 
to 165) compared to non-exercising controls (129±44; 95% CI, 111 to 147; p<0.001) [14]. Porserud et 245 
al. (2014) measured lower body strength using a 30-second chair stand test and found no significant 246 
differences between the intervention and control group. Porserud et al. also measured balance by 247 
asking patients to walk two laps in a figure of eight drawn on the floor, with a walking aid if 248 
necessary and found no significant differences between intervention and control group post-249 
intervention or one year later [21].  250 
Physical function 251 
Three studies measured physical function, two using the EORTC-QLQ-30 [18, 24] and one using the 252 
SF-36 [21]. No statistical differences were found, except for Karl et al.'s (2014) study, which found 253 
statistically higher physical functioning scores on postoperative day 3 for patients in the ERAS group. 254 
Dyspnoea  255 
Dyspnoea was measured in two studies using the EORTC-QLQ-30 [18, 24]. Jensen et al. (2014) found 256 
a 10% significant decrease in symptoms of dyspnoea in the intervention group (physical exercise 257 
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rehabilitation) compared with the control group at four month follow-up. Karl et al. (2014) reported 258 
no significant differences between intervention and control group after the ERAS protocol. 259 
Insomnia 260 
Insomnia was measured in two studies using the EORTC-QLQ-30 [18, 24] and no significant 261 
differences between intervention and control groups were found after the intervention. 262 
Sexual function 263 
Two studies measured sexual function [18, 29]. Jensen et al. (2014) found an improvement of 7% in 264 
sexual interest and activity in the control group four months after the intervention, which they 265 
described as clinically relevant though it was not statistically significant. Vidal et al. (2016) measured 266 
sexual function as a long-term follow-up to the TPN nutritional intervention described by Roth et al. 267 
(2013) and found no statistically significant differences between intervention and control group at 0, 268 
3, 12 and 24 month follow-ups.  269 
Psychological adjustment after surgery 270 
Social and emotional functioning 271 
Four studies measured social and emotional functioning using EORTC-QLQ-30 [18, 24], the SF-36 [21] 272 
and the SIP questionnaire [1]. No study found statistically significant differences between 273 
intervention and control groups after the intervention except Karl et al. (2014) who found a stable 274 
emotional functioning score during hospitalisation in the control group and continuous 275 
improvement in emotional functioning until discharge in patients exposed to the ERAS protocol (no 276 
data reported) [24].  277 
Health related quality of life 278 
Five studies measured QOL, one using the FACT-BL [25], two using global health-related QOL from 279 
the EORTC-QLQ-30 and functional subscales [18, 24] and two using the SF-12 or 36 [21, 29]. Porserud 280 
et al. (2014) found no statistically significant differences between intervention and control group in 281 
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the QOL domains [21]. Jensen et al. (2014) found the physical rehabilitation intervention group 282 
demonstrated a clinically relevant decrease compared to the control group on role function and 283 
cognitive function at the 4 month follow-up, although differences were not statistically significant. 284 
Frees et al. (2017) and Vidal et al. (2016) found no statistically significant differences between 285 
intervention and control groups in QOL scores.  286 
Self-care and self-efficacy 287 
Three studies measured self-care [13, 15, 20] and two measured self-efficacy [13, 15] as outcomes of 288 
the intervention. Jensen et al. (2015) found the ability to independently perform personal activities 289 
of daily living was significantly reduced by one day in the intervention group after pre-and 290 
postoperative physical exercise intervention compared to controls (3 days vs 4 days; p≤0.05) [20]. 291 
Jensen et al. (2017) found no statistical significant difference (p=0.35) in mean self-efficacy score 292 
between treatment groups on admission to surgery. However, a significant increase in the total 293 
stoma self-care score of 2.7 points (95% CI, 0.9 to 4.5) was found in the intervention group 294 
compared to the standard procedure group at postoperative day 35, and differences continued at 295 
day 120 (4.3 95% CI, 2.1 to 6.5) and 365 (5.1 95% CI, 2.3 to 7.8) [13]. Merandy et al. (2017) found 296 
that the single preoperative educational intervention was not associated with self-care 297 
independence scores (p=0.4286) and brought about no significant change in self-care or self-efficacy 298 
scores.  299 
Other outcomes 300 
Other outcome measures explored in isolation included vitality [21], mental health [21] and anxiety 301 
[12]. Porserud et al. (2014) found no significant differences between intervention and control group 302 
in vitality and mental health scores as measured by the SF-36. Ali and Khalil (1989) found patients 303 
who received psychoeducational preparation prior to surgery showed less state anxiety on the third 304 
day postoperatively than the control group (p<0.00 [sic]) and before discharge (p<0.00 [sic]) 305 
compared to controls. Through a qualitative analysis, Ali and Khalil (1989) also found that patients 306 
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fears and worries before surgery concerned i) cancer, ii) mutilation and body image distortion, and 307 
iii) impact on social/marital relationships. 308 
Complications 309 
Eleven studies reported complications associated with the surgical procedures, seven using the 310 
standardised Clavien-Dindo classification system [14, 17, 20, 25-28] (See Additional file 2). Generally, 311 
interventions were not found to substantially increase the normal complication rate, with the 312 
exception of one study that was terminated prematurely due to high gastrointestinal complications 313 
in patients exposed to total parenteral nutrition (TPN) for 5 days postoperatively [27]. 314 
Adherence and fidelity 315 
Adherence to the intervention was reported in eight articles. Table 4 gives a summary of the 316 
adherence reported in each of the articles under review. Eleven articles did not report adherence to 317 
the intervention. Fidelity of the intervention delivery was not reported in any article.  318 
[insert Table 4 here] 319 
Risk of bias 320 
Figure 2 shows the risk of bias summary table for the studies included. The standard of reporting 321 
was generally low, with many articles omitting Consolidated Standards of Reporting Trials 322 
(CONSORT) details [31]. Low reporting quality meant the majority of studies were judged to have 323 
unclear risk of bias on at least one domain. All studies were described as having randomised designs, 324 
but only ten articles reported the randomisation procedure (e.g., web-based block randomisation 325 
[18]). In eight articles, it was unclear how participants were randomised. One study was described as 326 
randomised but did not describe a true randomisation procedure, therefore considered high risk of 327 
bias [15]. Seven studies were rated low risk for 'selection bias', because they referred to allocation 328 
concealment in their reporting of the randomisation procedure [13, 18-21, 23]. Studies tended to be 329 
rated as unclear or high risk for 'performance bias' and 'detection bias' because it was unclear 330 
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whether patients, study personnel or outcome assessors were blind to the treatment group. Double-331 
blind RCTs are difficult, if not impossible for many non-pharmaceutical intervention studies, 332 
exposing most of the studies to performance bias. Two studies included in the review were 333 
described as double-blind [16, 23]. All studies were judged to be at high risk of some 'other bias'. 334 
This included, use of a single centre [12], different surgical and treatment procedures across 335 
different sites [16], LOS being influenced by hospital discharge rules (rather than health outcomes) 336 
[26], small sample sizes [1, 12, 17, 21, 22, 26], change over time in surgical procedure [18-20], 337 
intervention and control group patients being treated on the same hospital ward [18-20], use of 338 
male patients only [17], not recruiting the target sample size [21, 28] and premature termination of 339 
the study [27, 29].  340 
Figure 2 Risk of bias summary table 341 
Heterogeneity and sensitivity analyses  342 
Differences in the included studies, particularly in types of interventions, definitions of outcomes 343 
and tools used to measure outcomes meant sensitivity analyses could not be conducted and 344 
heterogeneity could not be assessed statistically. 345 
Discussion 346 
Supportive interventions for cystectomy patients have included exercise therapy, pharmaceuticals, 347 
ERAS protocols, psychological/educational programmes, chewing gum and nutrition delivered at 348 
various stages over the perioperative period. It is difficult to make clear recommendations for 349 
clinical practice, especially for potential long-term benefits to patient health, but this review can 350 
offer suggestions for potential short-term benefits of interventions.  351 
Review findings suggest that integrating exercise therapy into the pre- or postoperative care of 352 
cystectomy patients could have clinically important benefits for bowel function, physical function, 353 
strength/power, mobilisation and QOL but is not always feasible for patients. The findings align with 354 
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other reviews demonstrating the positive effects of exercise for bladder cancer patients [32]. 355 
Exercise can be challenging for cancer patients and requires careful consideration with respect to 356 
patient age and comorbidities [18, 33]. Research exploring the optimal type of exercise therapy 357 
would be informative, as intensive exercise may not always be appropriate [21] or accessible [14] for 358 
patients undergoing cystectomy.  359 
Cystectomy patients may benefit from pharmaceutical intervention for pain relief and physical 360 
function in the immediate postoperative period, which is likely to have a positive impact on length of 361 
hospital stay, QOL, the patient experience and healthcare costs. However, the effect on pain 362 
management might be short-lived and side-effects such as the sedative effect of pregabalin should 363 
be considered [22, 23].  364 
Only three of the included studies used ERAS protocols [17, 24, 25], supporting the observation that 365 
the adoption of ERAS protocols in urological procedures to date has been low [6]. The findings 366 
suggest that ERAS protocols have the potential to offer widest range of benefits for cystectomy 367 
patients. However, it is hard to identify what actually works within each context and the quality and 368 
quantity of the evidence needs improvement. Tyson and Chang (2016) systematically reviewed 13 369 
studies comparing ERAS after cystectomy versus standard care with a meta-analysis of effectiveness. 370 
ERAS protocols were investigated within observational studies only and were found to reduce the 371 
LOS, time-to-bowel function, and rate of complications after cystectomy, but the pooled estimates 372 
were biased in favour of ERAS and each perioperative pathway was different within each study [9]. If 373 
ERAS protocols are to be adopted, then high-quality multicentre studies are needed to accumulate 374 
evidence supporting the short and long-term impact of their use. 375 
The findings demonstrate that psychologically-supportive and educational interventions are less 376 
common than physical or medical interventions, but could reduce postoperative anxiety and 377 
promote postoperative adjustment, self-care and coping in cystectomy patients. Such outcomes are 378 
likely to benefit QOL and positive adjustments with clinical relevance [13], but are likely to require a 379 
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longer and more individualised approach than those implemented in the studies included in this 380 
review. The findings are consistent with a previous systematic review of exercise and psychosocial 381 
rehabilitation interventions to improve health-related outcomes in patients with bladder cancer 382 
undergoing radical cystectomy, which found limited evidence for beneficial effects of psychosocial 383 
interventions [32]. Given that poor preoperative mental health has been associated with 384 
complications after cystectomy [34] and postoperative problems can have a significant impact on 385 
QOL [5], assessing perioperative psychological health status could help identify those patients who 386 
may be in need of extra support. Further research is required to explore the best approach to 387 
provision of psychological support for patients to ensure that patients are not only surviving, but 388 
surviving well. 389 
Asking cystectomy patients to chew gum postoperatively may have benefits for bowel function and 390 
is unlikely to have any adverse effects. The early introduction of diet was feasible and safe, but TPN 391 
was associated with an increased rate of infectious complications, impaired bowel function, as well 392 
as higher costs [27].  393 
Some level of bias was present in all studies included in this review, with most of the uncertainty in 394 
judging bias coming from lack of clarity of randomisation and blinding procedures. Methodological 395 
details were underreported and future publications should adequately report high quality research. 396 
No study reported fidelity of intervention delivery meaning it was unclear whether the treatment 397 
was delivered as intended. Additionally, the surgical procedure, including form of urinary diversion 398 
to control group patients varied across studies (see Table 1), introducing potentially confounding 399 
factors. This makes it difficult to show whether any health benefits were related to the supportive 400 
intervention or to determine the optimal 'dosage' or exposure to the intervention required to bring 401 
about health benefits. Many of the studies lacked statistical power due to small sample sizes 402 
meaning statistical significance should be interpreted with caution. 403 
Recommendations for future research 404 
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Implications for clinical practice have been difficult to make, suggesting that future research should 405 
explore the clinical relevance of the outcomes found in research studies. Maintenance data through 406 
longer follow-ups are essential to explore i) long-term complications and readmissions and ii) 407 
whether short-term health outcomes are sustained over time. Adequately powered clinical trials are 408 
required to explore the long-term effects of physical prehabilitation and rehabilitation for 409 
cystectomy survivors. More research exploring psychologically-supportive interventions would be 410 
informative because the current findings highlight that psychological and behavioural outcomes 411 
(e.g., self-care behaviour and behaviour change) are scarcely studied and poorly understood. 412 
Standards of reporting must be improved, including details of fidelity and adherence. 413 
Conclusions 414 
This review provides a broad overview of the non-surgical supportive interventions available to help 415 
optimise the health outcomes of patients undergoing cystectomy procedures. It has shown that 416 
supportive interventions have taken many different forms with a range of potentially meaningful 417 
physiological and psychological health outcomes for patients in the short and long term after 418 
surgery. Questions remain as to what magnitude of improvements in the physiological and 419 
psychological health outcomes reported would lead to actual changes in the patient experience of 420 
surgery and recovery. Whilst this review can offer suggestions for potential benefits of interventions, 421 
clarification is required to understand what forms of support are most effective in improving the 422 
long-term quality of life of cystectomy patients. 423 
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Table 1 Summary of study details and participant characteristics  
Reference and 
country 






Urinary diversion type 
Surgery 
type 
Total INT CONT INT CONT 
Ali et al., 1989 
Egypt [12] 
30 15 15 Mean 45.33 
SD 5.9  
Mean 45.86 
SD 4.4 
Male = 23 
Female = 7 
Bladder 
cancer 
Urinary diversion   Not reported Not 
reported 
Banerjee et al., 2017 
UK [14] 




Male = 53 





urinary diversion  
Not reported Any 
surgical 
technique 
Choi et al., 2010 
Korea [26] 
62 30 31 Mean 63.5 
SD 4.5  
Mean 64.5 
SD 8.8   










Deibert et al., 2016 
USA [28] 
102 50 52 Not reported Not reported Male = 37 












Frees et al., 2017 
Canada [25] 




Male = 18 











Ghoneim & Hegazy, 
2013  
Egypt [22] 




Male = 45 






Not reported Not 
reported 
Jensen, Jensen et al., 
2014, 2015, 2016 , 
2017 
Denmark [13, 18-20] 




Male = 79 












Karl et al., 2014 
Germany [24] 








Lee et al., 2014  
USA [16] 




Male = 223 














Mansson et al., 1997  
Sweden [1] 




Orthotopic neobladder Not 
reported 
Merandy et al., 2017 
USA [15] 
8 4 4 Median 74.5 
IQR 73 - 81 
Median 72 
IQR 62 – 81.5 
Male = 8 












Mohamed et al., 
2016 
Egypt [23] 
60 45 (15 
per INT 
group) 





Male = 48 













Olaru et al., 2015  
Romania [17] 
20 10 10 Median 62.5 Median 62.0 Male = 20 











Porserud et al., 2014  
Sweden [21] 




Male = 14 






Ileal conduit Open 
Roth et al., 2013 [27] 
Vidal et al., 2016 [29] 
Switzerland 
 
157 74 83 Median 67 
Range 34 - 80 
Median 66 
Range 30 – 86 
Male = 106 















CONT= Control; INT= Intervention; SD= standard deviation  
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Exercise therapy Banerjee et al., 
2017 
Patients recruited 








Short-term preoperative vigorous intensity 
aerobic interval exercise on a cycle ergometer 
using the Borg Ratings of Perceived Exertion 
(RPE) Scale to control intensity. 5-10 warm up 
against light resistance (50W), patients aimed to 
perform 6 x 5min intervals to a target perceived 
exertion of 13-15 (somewhat hard to hard 
equating to 70-85% predicted max heart rate 
based on 220-age, with 2.5 min interpolated 
active rest intervals against light resistance 
(50W).  Instructed to maintain a steady pedalling 
cadence of 50-60 rev min-1 during intervals, and 
the exercise programme was progressed 
gradually adding more load to the flywheel to 
maintain the target perceived exertion. Followed 
by cool down against low resistance (50W). 
5-10 warm up.6 x 5min 
intervals with 2.5 min 
interpolated active rest 
intervals. Twice weekly 
over preoperative period 
until surgery (3-6 
weeks). Minimum of six 
sessions performed.  
Until discharge 
Jensen, Jensen 
et al., 2014  
Patients recruited 










Preoperative standardised exercise training 
programme at home; step training on a step 
trainer and muscle strength and endurance 
exercises. Postoperative mobilisation and 
rehabilitation; instructions for getting out of bed, 
mobilisation and walking.  
Exercise-based rehabilitation in the hospital; 
respiratory and circulatory exercises, 
mobilisation, walking, supervised standardised 
progressive muscle strength and endurance 
training. Patients discharged with a home 
training exercise programme.  
Preoperative 15 minutes 
step training and daily 
exercise programme 
consisting of six different 
exercises with 
individualised 




rehabilitation for 30 
minutes twice-daily for 
the first seven 
postoperative days.  
Day 35 and 4 
months 
postoperatively Jensen, 
Petersen et al., 
2015 
Jensen, 
Laustsen et al., 
2016  




from a single 






Postoperative group exercise training 
programme in the hospital; lower body strength 
and endurance training; walking and 
strengthening exercises, balance training, 
45 minutes twice a week 
for 12 weeks.  
Walks at a self-selected 
pace, 3-5 days a week 







mobility training and stretching exercises. Music 
was used as inspiration. Participants were also 
instructed to take walks at a self-selected pace. 
for at least 15 minutes. 























12 mg alvimopan before surgery and twice-daily 
doses postoperatively. 
Single dose (12 mg) 
between 30 minutes and 
5 hours before surgery 
and twice-daily doses 
postoperatively until 
hospital discharge or a 
maximum of 7 days (15 
in-hospital doses). 
Until discharge 











Group 2 300mg pregabalin orally 2 hour 
preoperative 
Group 3 300mg pregabalin orally 2 hour 
preoperative and 12 hour thereafter 
Group 4 600mg pregabalin orally 2 hour 
preoperative 
 




Frees et al., 
2017 
Patients recruited 





















ERAS protocol (see original study for details). Perioperative until 
discharge.   





















Ali et al., 1989 
 
Patients recruited 







Single, preoperative psychoeducational session 
provided to the patient and a significant other. 
Included explanation of the surgical procedure, 
site and appearance of stoma, device to be used 
1 x 30-60 minute 
session. 
Until discharge 




postoperatively, reasons for wearing a collection 
device, and a visit from another "ostomate" who 
is functioning well. Patients encouraged to 
express fears and anxieties regarding social 
aspects of living with a stoma, including clothing, 
changes in body image, sexuality, exercise, 
activity, and odour.  
Jensen, Kiesbye 
et al., 2017 
Patients recruited 












The education programme included basic skills to 
optimise the ability to perform independent 
stoma care. Patients encouraged to perform 
stoma care and change of appliance, both one-
piece and two-piece system, at least twice at 
home providing them with training kits and 
appliances. The patient was educated about the 
urostomy and life with a urostomy related to the 
individual patient's life and life style. Every 
patient had a follow up prior to surgery where 
the Urological Enteral Stoma Therapy Nurse 
observed self-care skills regarding stoma care 
and change of appliance. 
1 x education 
programme under 
supervision, 2 x practice 
at home, 1 x self-
demonstration under 
observation prior to 
surgery. 
Day 35 and 4 
months  and 12 
months 
postoperatively 










Psychosocial programme including weekly 
counselling, in the patient's home for four weeks, 
and thereafter by telephone. The discussion 
concerned consequences of the operation, 
practical and emotional problems, influences on 
mood and relations to partner and friends. The 
partner could be present at the interview.  
Weekly counselling for 
four weeks then via 
telephone for two 
weeks. 
3 months and 6 
months 
postoperatively 
Merandy et al., 
2017 
Patients recruited 








Multimethod educational intervention was 
developed for each of the three different urinary 
diversions and included (a) a simplified medical 
illustration of participant-specific urinary 
diversion, (b) a step-by-step urinary diversion 
self-care instructional video, and (c) a pictorial 
Microsoft PowerPoint®. The content was driven 
by Bandura’s (1977) four sources of self-efficacy 
and were based on first-hand observed 
difficulties experienced by patients with a urinary 
diversion. The video, PowerPoint, illustrations, 
and surveys were administered at the bedside by 
1 x 1 hour in duration, 
with an optional 30 







one of the investigators using a tablet computer. 
The intervention was enhanced by professional 
demonstration, followed by a chance for return 
demonstration.  
Chewing gum Choi et al., 2010 
 
Patients recruited 








Sugar-free chewing gum. 
 
30 minutes chewing 
three times daily at 
10am, 3pm and 8pm 




within 30 days 
Nutritional Deibert et al., 
2016 
Patients recruited 
from 2 hospital 
centres. Hospital 





Clear liquid diet on postoperative day 1 and 
access to a full regular diet from postoperative 





Roth et al., 2013 
 
Patients recruited 








Total parenteral nutrition (TPN). Nutriflex special; 
a solution with a total energy of 1240 
kcal/1000ml and containing polyamino acids, 
glucose, and electrolytes.  An additional 30 IU 
Actrapid HM and 1875 IU heparin per 24 hours 
were added to the TPN solution. 
Administered 
continuously for five 
days starting on 
postoperative day 1. 




up to 30 days 
postoperatively 
Vidal et al., 
2016 
3, 6, 12, 18, 24, 















































































































































































































Exercise therapy Banerjee et al. 2017 •         **              
Jensen et al.  2014   **  • ** • •   ** ** • •  • • •      
Jensen et al. 2015 • • • •     **          **     
Jensen et al.  2016          **              
Porserud et al.  2014 • •   •   • ** •     • • • •   • •  
Pharmaceutical  Ghoneim & Hegazy 2013     **  •                 
Lee et al.  2014 ** • ** **                    
Mohamed et al. 2016     **                   
Fast-track/ERAS 
protocol 
Frees et al. 2017 ** • **  ** ** •         •        
Karl et al. 2014 •  • ** •  • ** **  • • **   • • **      
Olaru et al.  2015 •  • •  •                  
Psychological / 
educational 
Ali et al. 1989                       ** 
Jensen et al. 2017                   ** •    
Mansson et al.  1997 •                • •      
Merandy et al. 2017                   • •    




Nutritional Deibert et al. 2016 • • • **                    




Vidal et al. 2016              •  •        
Total studies measuring that outcome 11 5 9 6 6 5 4 3 3 3 2 2 2 2 1 5 4 4 3 2 1 1 1 
 Not measured • Measured and not statistically significant ** Measured and statistically significant 
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Table 4 Adherence to the intervention 
Paper Adherence 
Ali et al., 1989 Not reported 
Banerjee et al., 2017 
The median number of supervised exercise sessions attended by patients in the 
exercise arm was 8 (range 1–10) over a preoperative period of 3–6 weeks. The 
average number of aerobic intervals achieved in the first week of exercise was 5.5 
(range 3.5–6.0), whereas all patients were achieving six intervals per session in the 
fourth week. 
Choi et al., 2010 Not reported 
Deibert et al., 2016 Not reported 
Frees et al., 2017 Not reported 
Ghoneim & Hegazy, 2013 100% adherence to pregabalin 
Jensen et al., 2014 
A total of 66 % (95 % confidence interval (CI) 51; 78) adhered more than 75% of the 
recommended progressive standardised exercise program. 
Jensen et al., 2015 
A total of 66 % (95 % confidence interval (CI) 51; 78) adhered more than 75% of the 
recommended progressive standardised exercise program. 
Jensen et al., 2016 
A total of 66 % (95 % confidence interval (CI) 51; 78) adhered more than 75% of the 
recommended progressive standardised exercise program. 
Jensen et al., 2017 Not reported 
Karl et al., 2014 Not reported 
Lee et al., 2014 119 out of 143 (83%) patients completed the alvimopan 
Mansson et al., 1997 Not reported 
Merandy et al., 2017 Not reported 
Mohamed et al., 2016 Not reported 
Olaru et al., 2015  Counselling and education was implemented in 90% of patients 
Porserud et al., 2014  
Participants attended a median of 76% (range 67–95%) of the group exercise 
training sessions and patients self-reported daily walks on 87% (56–100%) of the 
days during the 12-week period, averaging 3.5 hours (2–11.5%) per week 
Roth et al., 2013 Not reported 
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